343
Participants
Start Date
December 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Gadobutrol (Gadavist, Gadovist, BAY86-4875)
Gadobutrol single injection 0.1 mmol/kg BW via IV bolus administration at 2mL/sec.
Mount Sinai Medical Center, New York
Maimonides Medical Center, Brooklyn
University of Rochester Medical Center, Rochester
Allegheny General Hospital, Pittsburgh
Hahnemann University Hospital, Philadelphia
Wake Forest University School of Medicine, Winston-Salem
Medical University of South Carolina, Charleston
River Birch Research Alliance, LLC, Blue Ridge
Eisenhower Army Medical Center, Fort Gordon
University of Florida - Jacksonville, Jacksonville
University of South Florida, Tampa
Bio-Magnetic Resonance, Inc., Madison Heights
Henry Ford Health System, Detroit
Baylor College of Medicine, Houston
HOPE Research Institute, LLC, Phoenix
Scottsdale Medical Imaging, Ltd., Scottsdale
Radiology Ltd., Tucson
Landmark Imaging Medical Group, Los Angeles
Cedars- Sinai Medical Center, Los Angeles
Sharp & Children's MRI Center, San Diego
Chinese PLA General Hosp., Beijing
Affiliated Ruijin Hosp. Shanghai Jiaotong Univ. Med School, Shanghai
Fudan University Huashan Hospital, Shanghai
Zhongda Hosp. affiliated of Southeast Univ., Nanjing
The 1st Affiliated Hosp of the 4th Military Med Uni, Xi'an
University of Michigan Health System, Ann Arbor
Investigaciones Médicas, Buenos Aires
Milbet Diagnostico por Imagenes, Buenos Aires
Hospital Italiano Buenos Aires, Buenos Aires
Centro de Diagnóstico Dr. Enrique Rossi, Buenos Aires
Fundación Instituto de Alta tecnología médica de Antioquia, Medellín
Fundación Santa Fe de Bogotá - Hospital Universitario, Bogotá
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University College of Medicine, Seoul
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Bayer
INDUSTRY